American Health Packaging has issued a voluntary recall for approximately 6,579 cartons of Doxycycline Hyclate Tablets, USP, 100 mg. This recall affects the 30-tablet cartons containing unit dose blisters used for treating various bacterial infections. The medication is being recalled because it failed dissolution testing, which means the tablets may not dissolve properly in the body to release the active medicine as intended. Consumers who have these specific tablets should contact their healthcare provider or pharmacist for guidance on continuing their treatment.
If the medication does not dissolve correctly, the patient may not receive the full dose of the antibiotic, potentially leading to ineffective treatment of their bacterial infection. No specific injuries or adverse health consequences have been reported to date.
Healthcare provider consultation and pharmacy refund
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.